These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 18051411)

  • 1. [Biological diversity of protein lysine acetylation which has been revealed by small molecule inhibitors].
    Shimazu T; Horinouchi S; Yoshida M
    Tanpakushitsu Kakusan Koso; 2007 Oct; 52(13 Suppl):1751-7. PubMed ID: 18051411
    [No Abstract]   [Full Text] [Related]  

  • 2. [Histone deacetylase inhibitors--new anticancer agents?].
    Yoshida M; Horinouchi S
    Tanpakushitsu Kakusan Koso; 2000 Apr; 45(6 Suppl):1090-5. PubMed ID: 10771678
    [No Abstract]   [Full Text] [Related]  

  • 3. [A new target of cancer therapy: advances in the study of histone deacetylase].
    Liu AL; Long J; Wang N; Du GH
    Yao Xue Xue Bao; 2005 Jul; 40(7):585-90. PubMed ID: 16196262
    [No Abstract]   [Full Text] [Related]  

  • 4. Acetylation of non-histone proteins modulates cellular signalling at multiple levels.
    Spange S; Wagner T; Heinzel T; Krämer OH
    Int J Biochem Cell Biol; 2009 Jan; 41(1):185-98. PubMed ID: 18804549
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Histone post-translational modification: from discovery to the clinic.
    Thomas NR
    IDrugs; 2006 Jun; 9(6):398-401. PubMed ID: 16752306
    [No Abstract]   [Full Text] [Related]  

  • 6. HATs and HDACs: from structure, function and regulation to novel strategies for therapy and prevention.
    Yang XJ; Seto E
    Oncogene; 2007 Aug; 26(37):5310-8. PubMed ID: 17694074
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epi-drugs to fight cancer: from chemistry to cancer treatment, the road ahead.
    Mai A; Altucci L
    Int J Biochem Cell Biol; 2009 Jan; 41(1):199-213. PubMed ID: 18790076
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HDAC2 deficiency and histone acetylation.
    Ree AH; Folkvord S; Flatmark K
    Nat Genet; 2008 Jul; 40(7):812-3; author reply 813. PubMed ID: 18583969
    [No Abstract]   [Full Text] [Related]  

  • 9. [Potent and specific inhibition of mammalian histone deacetylase both in vivo and in vitro by trichostatin A].
    Yoshida M
    Tanpakushitsu Kakusan Koso; 2007 Oct; 52(13 Suppl):1788-9. PubMed ID: 18051427
    [No Abstract]   [Full Text] [Related]  

  • 10. Histone deacetylase inhibitors in cancer therapy.
    Fouladi M
    Cancer Invest; 2006; 24(5):521-7. PubMed ID: 16939962
    [No Abstract]   [Full Text] [Related]  

  • 11. Synthesis and modeling of new benzofuranone histone deacetylase inhibitors that stimulate tumor suppressor gene expression.
    Charrier C; Clarhaut J; Gesson JP; Estiu G; Wiest O; Roche J; Bertrand P
    J Med Chem; 2009 May; 52(9):3112-5. PubMed ID: 19385600
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ultraviolet radiation-induced transcription is associated with gene-specific histone acetylation.
    Pollack BP; Sapkota B; Boss JM
    Photochem Photobiol; 2009; 85(3):652-62. PubMed ID: 19076306
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hydroxychloroquine, chloroquine, and all-trans retinoic acid regulate growth, survival, and histone acetylation in breast cancer cells.
    Rahim R; Strobl JS
    Anticancer Drugs; 2009 Sep; 20(8):736-45. PubMed ID: 19584707
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Toward an HDAC6 inhibitor: synthesis and conformational analysis of cyclic hexapeptide hydroxamic acid designed from alpha-tubulin sequence.
    Jose B; Okamura S; Kato T; Nishino N; Sumida Y; Yoshida M
    Bioorg Med Chem; 2004 Mar; 12(6):1351-6. PubMed ID: 15018907
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting oxidative stress in cancer.
    Lawless MW; O'Byrne KJ; Gray SG
    Expert Opin Ther Targets; 2010 Nov; 14(11):1225-45. PubMed ID: 20942747
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Histone acetyl transferases as emerging drug targets.
    Dekker FJ; Haisma HJ
    Drug Discov Today; 2009 Oct; 14(19-20):942-8. PubMed ID: 19577000
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Histone deacetylase inhibitors that target tubulin.
    Schemies J; Sippl W; Jung M
    Cancer Lett; 2009 Aug; 280(2):222-32. PubMed ID: 19268440
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Trichostatin A and nuclear reprogramming of cloned rabbit embryos.
    Shi LH; Ai JS; Ouyang YC; Huang JC; Lei ZL; Wang Q; Yin S; Han ZM; Sun QY; Chen DY
    J Anim Sci; 2008 May; 86(5):1106-13. PubMed ID: 18245503
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Zn(II)-dependent histone deacetylase inhibitors: suberoylanilide hydroxamic acid and trichostatin A.
    Codd R; Braich N; Liu J; Soe CZ; Pakchung AA
    Int J Biochem Cell Biol; 2009 Apr; 41(4):736-9. PubMed ID: 18725319
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chemical genomics: a key to the epigenome - an interview with Minoru Yoshida. Interview by Saadi Khochbin.
    Yoshida M
    Int J Dev Biol; 2009; 53(2-3):269-74. PubMed ID: 19412886
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.